市場調査レポート
商品コード
1386934
静注用免疫グロブリンの世界市場:動向、予測、競合分析(~2030年)Intravenous Immunoglobulin Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
静注用免疫グロブリンの世界市場:動向、予測、競合分析(~2030年) |
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
静注用免疫グロブリンの動向と予測
世界の静注用免疫グロブリンの市場規模は、2024~2030年にかけてCAGR 7.6%で成長し、2030年までに約246億米ドルに達すると予測されています。この市場の主な促進要因は、高齢者人口の増加、血友病患者の増加、免疫グロブリンの生成に関する新技術、精製方法の改善(血漿収率の向上)です。世界の静注用免疫グロブリン市場の将来は、病院、在宅医療、専門クリニックの各市場におけるビジネスチャンスで有望視されています。
静注用免疫グロブリン市場の洞察
Lucintelの予測によると、免疫不全症は、個々の患者に基づいた診断と治療への注目が高まっていることと、患者のほとんどが自己投与に適応できないため、患者のトレーニングが必要であることから、予測期間中も最大セグメントであり続けるという。
この市場において、病院が最大のセグメントであり続けると思われます。これは、原発性免疫不全症やc型肝炎、その他の疾患の有病率の増加により、世界中で入院患者数が急増し、病院薬局の需要が増加しているためです。
北米は、臨床医の間で治療に対する需要が高まっていること、ヘルスケア支出が増加していること、大手企業が進出していることなどから、今後も最大地域であり続けると思われます。
Intravenous Immunoglobulin Trends and Forecast
The future of the global intravenous immunoglobulin market looks promising with opportunities in the hospital, homecare, and specialty clinic markets. The global intravenous immunoglobulin market is expected to reach an estimated $24.6 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing geriatric population, rising number of hemophiliacs, and new technologies related to the generation of immunoglobulin, and improved purification methods (with improved plasma yield).
A more than 150-page report is developed to help in your business decisions.
Intravenous Immunoglobulin by Segment
The study includes a forecast for the global intravenous immunoglobulin by application, distribution channel, end use, form, and region.
Intravenous Immunoglobulin Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Intravenous Immunoglobulin Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
Intravenous Immunoglobulin Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Intravenous Immunoglobulin Market by Form [Shipment Analysis by Value from 2018 to 2030]:
Intravenous Immunoglobulin Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Intravenous Immunoglobulin Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intravenous immunoglobulin companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intravenous immunoglobulin companies profiled in this report include-
Intravenous Immunoglobulin Market Insights
Lucintel forecasts that immunodeficiency diseases will remain the largest segment over the forecast period due to increasing focus towards the diagnosis and treatment based on individual patient and training of patients as most of the patients are not adaptable towards self administration.
Within this market, hospital will remain the largest segment due to the increasing prevalence of primary immunodeficiency and hepatitis c, as well as other diseases, has led to surge in hospitalizations around the world, thus increasing the demand for hospital pharmacies.
North America will remain the largest region due to growing demand of therapies among clinicians, rising healthcare expenditure, and presence of major players in the region.
Features of the Global Intravenous Immunoglobulin Market
Market Size Estimates: Intravenous immunoglobulin market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Intravenous immunoglobulin market size by various segments, such as by application, distribution channel, end use, form, and region in terms of value ($B).
Regional Analysis: Intravenous immunoglobulin market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different applications, distribution channels, end uses, forms, and regions for the intravenous immunoglobulin market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intravenous immunoglobulin market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the intravenous immunoglobulin market size?
Answer: The global intravenous immunoglobulin market is expected to reach an estimated $24.6 billion by 2030.
Q.2 What is the growth forecast for intravenous immunoglobulin market?
Answer: The global intravenous immunoglobulin market is expected to grow with a CAGR of 7.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the intravenous immunoglobulin market?
Answer: The major drivers for this market are increasing geriatric population, rising number of hemophiliacs, and new technologies related to the generation of immunoglobulin, and improved purification methods (with improved plasma yield).
Q4. What are the major segments for intravenous immunoglobulin market?
Answer: The future of the global intravenous immunoglobulin market looks promising with opportunities in the hospital, homecare, and specialty clinic markets.
Q5. Who are the key intravenous immunoglobulin market companies?
Answer: Some of the key intravenous immunoglobulin companies are as follows:
Q6. Which intravenous immunoglobulin market segment will be the largest in future?
Answer: Lucintel forecasts that immunodeficiency diseases will remain the largest segment over the forecast period due to increasing focus towards the diagnosis and treatment based on individual patient and training of patients as most of the patients are not adaptable towards self administration.
Q7. In intravenous immunoglobulin market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to growing demand of therapies among clinicians, rising healthcare expenditure, and presence of major players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.